Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd has informed BSE that its Board of Directors will meet on Friday, 7th November 2025. The Board will primarily consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September 2025 (Q2 FY26). The filing was made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. Additionally, any other business items may be taken up with the Board's permission. This is a routine pre-results intimation and no actual financial figures have been disclosed yet.
No immediate impact on shareholders or the stock price since this is a standard advance notice of an upcoming board meeting. Investors should watch for the actual Q2/H1 FY26 results announcement on or after 7th November 2025 for any meaningful business or financial updates.